[Bio-Medical/Healthcare]
HAII
-
Desired form of investment :
VC investment(series-B)
-
Year of establishment : 2016
-
HAII is developing innovative digital therapeutics in the prevention and management of mental health and disease such as dementia, depression, and anxiety disorders.
HAII is striving to overcome the limitations of previous medicines and drugs using IT technologies. We are developing software therapeutics based on peer-reviewed research without the use of any physical stimulation or drugs. This therapy does not inject medicine directly into the body and is relatively low risk compared to previous treatments.
CEO: Kim Jinwoo
Number of employees : 34
Business Structure : B2B / B2B2C
Key Technology : Digital bio marker (UI/UX)
Website : www.haii.io
Reason to Invest(Our Product & Service)
- Alzuguard : MCSIscreenign service
* Core technology : SW-based digital bio-marker
* Service indicators : Pilot test in local, 200 people(2021), Conformatin of medical device compatibility from KFDA(2022)
Our Achievement
2022 : 1 commercializtion of wellness service, 1 compatinility of medical device 8 domestic patents registedred
2021 : 1 conformation of pivotal clinical trial from KFDA
2020 : 1 license out
Inquiry
Want more information about this company? Leave a message and we will contact you.
We recognize the importance of privacy and confidentiality of personal information.
We protect and use personal information about you in limited scope by
Korea Personal Information Act and our
Privacy Policy.
If you have read and agreed to our privacy policy, check the boxes and
click "Send" button.